Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06550362 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 2026 to Dec 2026v7
  2. Primary and study completion dates: May 2026 to May 2027
    • Start date: Dec 2025 to May 2026
    v6
  3. Start date: Sep 2025 to Dec 2025v5
  4. Start date: May 2025 to Sep 2025v4
  5. Start date: Jan 2025 to May 2025
    • Primary and study completion dates: Nov 2025 to May 2026
    • Primary endpoints revised (2)
    • Secondary endpoints shortened, about 2 words
    v3
  6. Primary completion date: Nov 2024 to Nov 2025
    • Start date: Sep 2024 to Jan 2025
    • Study completion date: Feb 2025 to Nov 2025
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.
Trial Details
NCT Number NCT06550362
Lead Sponsor Loma Linda University
Conditions
(from sponsor)		 Iron Deficiency Anemia
Related terms Anemia, Iron-Deficiency
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov